Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Net Cash Flow (2018 - 2025)

Exagen's Net Cash Flow history spans 8 years, with the latest figure at -$3.4 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 343300.0% year-over-year to -$3.4 million; the TTM value through Dec 2025 reached $10.2 million, up 170.44%, while the annual FY2025 figure was $10.2 million, 170.44% up from the prior year.
  • Net Cash Flow reached -$3.4 million in Q4 2025 per XGN's latest filing, down from $5.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $60.6 million in Q1 2021 to a low of -$20.7 million in Q2 2023.
  • Average Net Cash Flow over 5 years is -$1.3 million, with a median of -$5.6 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: skyrocketed 1863.74% in 2021, then plummeted 343300.0% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$7.3 million in 2021, then increased by 13.8% to -$6.3 million in 2022, then soared by 227.44% to $8.0 million in 2023, then tumbled by 99.99% to $1000.0 in 2024, then tumbled by 343300.0% to -$3.4 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Net Cash Flow are -$3.4 million (Q4 2025), $5.6 million (Q3 2025), and $18.8 million (Q2 2025).